Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection.

Norton BL, Park L, McGrath LJ, Proeschold Bell RJ, Muir AJ, Naggie S.

AIDS Patient Care STDS. 2012 Sep;26(9):541-5. doi: 10.1089/apc.2012.0170.

2.

Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study.

Johnson TL, Toliver JC, Mao L, Oramasionwu CU.

BMC Infect Dis. 2014 Apr 23;14:217. doi: 10.1186/1471-2334-14-217.

3.

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

Lo Re V 3rd, Volk J, Newcomb CW, Yang YX, Freeman CP, Hennessy S, Kostman JR, Tebas P, Leonard MB, Localio AR.

Hepatology. 2012 Nov;56(5):1688-98. doi: 10.1002/hep.25866.

4.

Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection.

Tencer T, Friedman HS, Li-McLeod J, Johnson K.

J Manag Care Pharm. 2007 Nov-Dec;13(9):790-8.

5.

Hepatitis C prevalence in HIV-infected individuals: a comparison of inpatient and outpatient care.

Zhu Z, Dhir T, Soe M, Green L, Jiang N.

Int J STD AIDS. 2014 Oct;25(11):806-11. doi: 10.1177/0956462414521169.

PMID:
24492852
6.

Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.

Fleishman JA, Gebo KA, Reilly ED, Conviser R, Christopher Mathews W, Todd Korthuis P, Hellinger J, Rutstein R, Keiser P, Rubin H, Moore RD; HIV Research Network..

Med Care. 2005 Sep;43(9 Suppl):III40-52.

PMID:
16116308
8.

HIV-infected inpatients in the HAART era: how do hepatitis C virus coinfected patients differ?

Falusi OM, Pulvirenti J, Sarazine J, Shastri P, Gail C, Glowacki R.

AIDS Patient Care STDS. 2003 Jan;17(1):13-6.

PMID:
12614516
9.

HIV AND HEPATITIS C VIRUS COINFECTION. WHO IS THIS PATIENT TODAY?

Antonello VS, Antonello IC, Zaltron RF, Tovo CV.

Arq Gastroenterol. 2016 Jul-Sep;53(3):180-4. doi: 10.1590/S0004-28032016000300011.

10.

Therapy of hepatitis C in HIV-coinfection.

Rockstroh JK, Vogel M.

Eur J Med Res. 2004 Jun 30;9(6):304-8. Review.

PMID:
15257871
11.

Neuropsychiatric impact of hepatitis C on advanced HIV.

Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P; Manhattan HIV Brain Bank..

Neurology. 2004 Mar 23;62(6):957-62.

12.
13.

Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection.

Garg S, Hoenig M, Edwards EM, Bliss C, Heeren T, Tumilty S, Walley AY, Koziel MJ, Skolnik PR, Horsburgh CR, Cotton D.

AIDS Patient Care STDS. 2011 Mar;25(3):135-41. doi: 10.1089/apc.2010.0104.

14.

Lower Ribavirin Plasma Concentrations in HCV/HIV-Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage.

Deenen MJ, de Kanter CT, Dofferhoff AS, Grintjes-Huisman KJ, van der Ven AJ, Fleuren HW, Gisolf EH, Koopmans PP, Drenth JP, Burger DM.

Ther Drug Monit. 2015 Dec;37(6):751-5. doi: 10.1097/FTD.0000000000000226.

PMID:
26102531
15.

Comorbidities and their impact on mortality in HCV and HCV-HIV-coinfected persons on dialysis.

Butt AA, Khan UA, Skanderson M.

J Clin Gastroenterol. 2008 Oct;42(9):1054-59.

PMID:
19013829
16.

Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.

Kruse RL, Kramer JR, Tyson GL, Duan Z, Chen L, El-Serag HB, Kanwal F.

Hepatology. 2014 Dec;60(6):1871-8. doi: 10.1002/hep.27337.

17.

Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV/HCV who have alcohol problems.

Palepu A, Cheng DM, Kim T, Nunes D, Vidaver J, Alperen J, Saitz R, Samet JH.

J Subst Abuse Treat. 2006 Dec;31(4):411-7.

18.

Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis.

Butt AA, Skanderson M, McGinnis KA, Ahuja T, Bryce CL, Barnato AE, Chang CC.

J Viral Hepat. 2007 Oct;14(10):688-96.

PMID:
17875003
19.

Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.

Kang F, Chen W, Zhang X, Nie W, Fu J, Xu X, Zhao P, Zhang X, Li W, Wang FS, Zhang Z, Zhao M.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):135-42. doi: 10.1097/QAI.0b013e3182752d20.

PMID:
23075912
20.

Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.

Weimer LE, Fragola V, Floridia M, Guaraldi G, Ladisa N, Francisci D, Bellagamba R, Degli Antoni A, Parruti G, Giacometti A, Manconi PE, Vivarelli A, D'Ettorre G, Mura MS, Cicalini S, Preziosi R, Sighinolfi L, Verucchi G, Libertone R, Tavio M, Sarmati L, Bucciardini R; ISS-NIA Study Group..

J Antimicrob Chemother. 2013 Jan;68(1):193-9. doi: 10.1093/jac/dks341.

Supplemental Content

Support Center